Ryouichi Tsunedomi
- Oncology top 5%
- Cancer Cells and Metastasis 14
- Cancer Immunotherapy and Biomarkers 11
- Pancreatic and Hepatic Oncology Research 6
- Colorectal Cancer Treatments and Studies 6
- Cancer Research top 5%
- MicroRNA in disease regulation 6
- Cancer Genomics and Diagnostics 6
- Hepatology top 5%
-
- Immunotherapy and Immune Responses 7
-
- Cancer therapeutics and mechanisms 5
- Co-authors
- Shoichi HazamaNobuaki SuzukiMasaaki OkaKiyoshi YoshimuraKazuhiko SakamotoHiroaki NaganoNorio IizukaMamoru Yamada
- Cited by
- OncologyCancer ResearchHepatology
- Partner nations
- JapanUnited StatesEgypt
In The Last Decade
Ryouichi Tsunedomi
61 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 99
- Oncology 610
- Cancer Research 335
- Hepatology 124
- Immunology 207
- Molecular Biology 671
Countries citing papers authored by Ryouichi Tsunedomi
This map shows the geographic impact of Ryouichi Tsunedomi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryouichi Tsunedomi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryouichi Tsunedomi more than expected).
Fields of papers citing papers by Ryouichi Tsunedomi
This network shows the impact of papers produced by Ryouichi Tsunedomi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryouichi Tsunedomi. The network helps show where Ryouichi Tsunedomi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ryouichi Tsunedomi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 6 | |
| 4 | 2023 | 10 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 5 | |
| 7 | 2022 | 8 | |
| 8 | 2022 | 20 | |
| 9 | 2020 | 67 | |
| 10 | 2017 | 4 | |
| 11 | 2016 | 42 | |
| 12 | 2014 | 13 | |
| 13 | 2014 | 9 | |
| 14 | 2014 | 18 | |
| 15 | 2013 | 27 | |
| 16 | Personalized Chemotherapy for Colorectal Cancer based on the genome information( Medical Care and Diagnosis) | 2012 | 0 |
| 17 | 2009 | 69 | |
| 18 | 2008 | 36 | |
| 19 | 2008 | 17 | |
| 20 | 2003 | 5 |
About Ryouichi Tsunedomi
Ryouichi Tsunedomi is a scholar working on Oncology, Cancer Research and Hepatology, having authored 64 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (14 papers), Cancer Immunotherapy and Biomarkers (11 papers), Immunotherapy and Immune Responses (7 papers), MicroRNA in disease regulation (6 papers), Pancreatic and Hepatic Oncology Research (6 papers), Cancer Genomics and Diagnostics (6 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer therapeutics and mechanisms (5 papers). The work is most often cited by research in Oncology (610 citations), Cancer Research (335 citations) and Hepatology (124 citations). Ryouichi Tsunedomi has collaborated with scholars based in Japan, United States and Egypt. Frequent co-authors include Shoichi Hazama, Nobuaki Suzuki, Masaaki Oka, Kiyoshi Yoshimura, Kazuhiko Sakamoto, Hiroaki Nagano, Norio Iizuka, Mamoru Yamada, Yoshihiko Hamamoto and Hiroko Takenouchi. Their work appears in journals such as Journal of Clinical Oncology, Biomaterials and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.